http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-101437067-B1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23V2200-308 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-505 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23V2002-00 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23L33-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-395 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 |
| filingDate | 2012-09-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2014-09-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2014-09-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-101437067-B1 |
| titleOfInvention | Pharmaceutical composition for preventing or treating graft-versus-host disease comprising anti-CXCL2 or anti-CXCR2 monoclonal antibody |
| abstract | The present invention provides a pharmaceutical composition for the prevention or treatment of graft-versus-host disease comprising an anti-CXCL2 or anti-CXCR2 monoclonal antibody. The pharmaceutical composition according to the present invention inhibits the access of the T-cell to the graft-versus-host disease target organs, thereby accelerating the migration of the cancer cell relatively, thereby preventing the graft-versus-host disease and enhancing the antitumor effect. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-107964045-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-107964045-B |
| priorityDate | 2012-09-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 157.